Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neelima Vidula, M.D.

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms122024209821.030 Why?
BRCA2 Protein220207970.980 Why?
Glutaminase12023320.880 Why?
BRCA1 Protein2202011490.870 Why?
Receptor Activator of Nuclear Factor-kappa B12017770.570 Why?
Carcinoma, Ductal, Breast1202410840.550 Why?
Diagnostic Tests, Routine120207880.450 Why?
Cyclin-Dependent Kinase 6120153480.400 Why?
Cyclin-Dependent Kinase 4120155590.380 Why?
Cerebellar Ataxia120121500.360 Why?
Paraneoplastic Syndromes120121550.360 Why?
Antineoplastic Agents, Hormonal2201915200.350 Why?
Molecular Targeted Therapy3202128130.340 Why?
Small Cell Lung Carcinoma120124240.280 Why?
Bone Neoplasms1201725270.240 Why?
Lung Neoplasms22024133850.240 Why?
Brain Diseases1201415450.240 Why?
Protein Kinase Inhibitors3202156620.230 Why?
High-Throughput Nucleotide Sequencing3202136340.230 Why?
Hematopoietic Stem Cells1201533880.210 Why?
Brain Neoplasms1202490250.210 Why?
Oxadiazoles12021940.190 Why?
Mutation32021300020.190 Why?
Prognosis42023296870.180 Why?
Neoplasms32021221400.180 Why?
Atrial Flutter120232520.180 Why?
Trophoblasts120222230.180 Why?
Piperazines4202025220.180 Why?
Receptor, trkA120211590.180 Why?
Glutamine120235740.180 Why?
Tachycardia, Supraventricular120232730.180 Why?
Gene Expression2202375710.170 Why?
Fatal Outcome1202418380.160 Why?
Lymphoproliferative Disorders120235310.160 Why?
Antineoplastic Agents32021136320.160 Why?
Neoplasm Recurrence, Local1201792780.160 Why?
Receptor, Fibroblast Growth Factor, Type 1120192560.150 Why?
Antigens, Surface1202216070.150 Why?
Phthalazines120203830.150 Why?
Female1620243925440.140 Why?
Hematopoietic Stem Cell Transplantation1201556660.140 Why?
Drug Resistance, Neoplasm4202053000.140 Why?
Osteoprotegerin120171770.140 Why?
Neoplasm Metastasis4202149090.130 Why?
Nitriles120219710.130 Why?
Cell Adhesion Molecules1202216030.130 Why?
Germ Cells120206320.130 Why?
RANK Ligand120173180.130 Why?
Lymphocytes, Tumor-Infiltrating1202110890.120 Why?
Estrogen Receptor alpha120195820.120 Why?
Antigens, Neoplasm1202219850.120 Why?
Humans2120247612080.110 Why?
Neoplastic Cells, Circulating120209430.110 Why?
Immunoconjugates120219630.110 Why?
Oncogene Proteins, Fusion1202116050.110 Why?
Neoplasm Staging32021111190.100 Why?
Drug Design1201710450.100 Why?
Receptors, Estrogen2201722080.100 Why?
Biopsy1202467810.100 Why?
Purines120156090.100 Why?
Radiotherapy, Adjuvant1201717840.100 Why?
DNA Mutational Analysis1202041070.100 Why?
Stroke1201497210.100 Why?
Aminopyridines120155730.090 Why?
Pyrazoles1202120100.090 Why?
Disease-Free Survival2202168190.090 Why?
Transplantation, Autologous1201521120.090 Why?
TOR Serine-Threonine Kinases1201920580.090 Why?
Pyridines3201928720.090 Why?
Benzimidazoles120158580.090 Why?
Middle Aged820242208530.080 Why?
Pyrimidines1202130270.080 Why?
Mastectomy1201718180.080 Why?
Diagnosis, Differential12024129760.080 Why?
Oligonucleotide Array Sequence Analysis1201737770.080 Why?
Chemotherapy, Adjuvant1201735120.080 Why?
Transplantation, Homologous1201548220.070 Why?
Genotype12021129850.070 Why?
Neoadjuvant Therapy1201728270.060 Why?
Sonication12006790.060 Why?
Lung Diseases1201519100.060 Why?
Apoptosis1202194770.060 Why?
Atrial Fibrillation1202351140.060 Why?
Gene Expression Regulation, Neoplastic1202085300.060 Why?
Multivariate Analysis12017120520.060 Why?
Cell Line, Tumor12020169520.050 Why?
Aged520211692880.050 Why?
Proportional Hazards Models12017124740.050 Why?
Logistic Models12017132490.050 Why?
Gene Expression Profiling1201794160.050 Why?
Tomography, X-Ray Computed12024205880.050 Why?
Osteoblasts1200611440.040 Why?
Indazoles120213040.040 Why?
Retrospective Studies22020806740.040 Why?
Maximum Tolerated Dose120218830.040 Why?
Osteogenesis1200612730.040 Why?
Class I Phosphatidylinositol 3-Kinases120218990.030 Why?
Tissue Engineering1200618650.030 Why?
Benzamides1202113710.030 Why?
Risk Assessment12017240210.030 Why?
Time Factors12017399570.030 Why?
PTEN Phosphohydrolase1202111110.030 Why?
Mesenchymal Stem Cells1200616450.030 Why?
Gene Amplification1201910840.030 Why?
Signal Transduction12017234160.030 Why?
Administration, Oral1202140150.030 Why?
Proto-Oncogene Proteins c-akt1202124550.030 Why?
Aromatase Inhibitors120165130.020 Why?
Receptors, Progesterone1201611290.020 Why?
Treatment Outcome12017646810.020 Why?
Hormone Replacement Therapy120167510.020 Why?
Risk Factors12017742390.020 Why?
Cardiovascular Diseases12015155200.020 Why?
Dose-Response Relationship, Drug12021107560.020 Why?
Estrogen Replacement Therapy1201612080.020 Why?
Tumor Suppressor Protein p531201929150.020 Why?
Male320233606930.020 Why?
Receptor, erbB-21201625530.020 Why?
Clinical Trials as Topic1202180030.020 Why?
Dose-Response Relationship, Radiation120068800.010 Why?
Adult120152211190.010 Why?
Microscopy120069040.010 Why?
Antineoplastic Combined Chemotherapy Protocols12019117330.010 Why?
Prospective Studies12023544350.010 Why?
Magnetic Resonance Imaging12006364150.010 Why?
Cell Culture Techniques1200616620.010 Why?
Radiation Dosage1200619620.010 Why?
Cells, Cultured12006189260.010 Why?
Cell Differentiation12006115090.000 Why?
Vidula's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.